In vitro activity of vancomycin, quinupristin/dalfopristin, and linezolid against intact and disrupted biofilms of staphylococci
<p>Abstract</p> <p>Shed cells or disrupted parts of the biofilm may enter the circulation causing serious and very hard to treat biofilm-associated infections. The activity of antimicrobial agents against the shed cells/disrupted biofilms is largely unknown.</p> <p>Meth...
Main Authors: | Kanchanapoom Termkiat, Rao Suma, El-Azizi Mohamed, Khardori Nancy |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2005-01-01
|
Series: | Annals of Clinical Microbiology and Antimicrobials |
Subjects: | |
Online Access: | http://www.ann-clinmicrob.com/content/4/1/2 |
Similar Items
-
The global prevalence of Daptomycin, Tigecycline, Quinupristin/Dalfopristin, and Linezolid-resistant Staphylococcus aureus and coagulase–negative staphylococci strains: a systematic review and meta-analysis
by: Aref Shariati, et al.
Published: (2020-04-01) -
Safety of intravitreal quinupristin/dalfopristin in an animal model
by: Veronica E. Giordano, et al.
Published: (2016-03-01) -
Antimicrobial susceptibility of quinupristin/dalfopristin tested against gram-positive cocci from Latin America: results from the Global SMART (GSMART) surveillance study
by: Sader Helio S., et al.
Published: (2001-01-01) -
In vitro antimicrobial activity of linezolid tested against vancomycin-resistant enterococci isolated in Brazilian hospitals
by: Adriana O. Reis, et al. -
In vitro antimicrobial activity of linezolid tested against vancomycin-resistant enterococci isolated in Brazilian hospitals
by: Reis Adriana O., et al.
Published: (2001-01-01)